Shake Shack’s stock rallies 15% as profit jumps
Post Content
R1 RCM to be taken over for $8.9 billion
Post Content
Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study
The data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.
Wayfair CEO likens home goods slowdown to 2008 financial crisis: ‘Customers remain cautious’
Online home goods company Wayfair has seen sluggish demand against high interest rates, but repreive could come if the federal reserve cuts rates in September